title: Interleukin-8 and acute kidney injury following cardiopulmonary bypass: a prospective cohort study.
abstract: BACKGROUND
  Cardiopulmonary bypass (CPB) elicits an inflammatory response mediated partly by neutrophils, which are activated and recruited by interleukin-8 (IL-8). We hypothesized that acute kidney injury (AKI) following CPB might be mediated by IL-8 and examined the association of perioperative plasma IL-8 levels with AKI in a prospective cohort.
  
  
  METHODS
  Plasma IL-8 was measured before, and 2, 24 and 48 h following CPB. Two AKI definitions, a serum creatinine increase of > or = 0.3 mg/dl or 50% (AKI Network [AKIN] stage-1) or > or = 50% alone (AKI-50%), within the first 72 h, were used. Area under the receiver operator characteristic curves (AUCs) were generated and multivariable logistic regression analyses performed.
  
  
  RESULTS
  A total of 143 patients were enrolled. The baseline mean serum creatinine was 1.1 mg/ dl (SD = 0.3), the CPB perfusion time was 112 min (SD = 43). Twenty-nine percent of the patients developed AKIN stage-1 and 13% AKI-50%. The plasma IL-8 level 2 h after CPB was higher in AKIN stage-1 (p = 0.03) and AKI-50% (p < 0.01), and predicted AKIN stage-1 (AUC = 0.62; p = 0.02) and AKI-50% (AUC = 0.72; p < 0.01). On multivariable analysis, the 2-hour plasma IL-8 level was associated with 1.36- and 1.59-fold higher odds for AKIN stage-1 and AKI-50%, respectively (p = 0.05).
  
  
  CONCLUSIONS
  Plasma IL-8 predicts the development of AKI following CPB, supporting a potential involvement for this chemokine in the pathogenesis of AKI.
authors: Division of Nephrology, Caritas St. Elizabeth's Medical Center, Boston, MA 02135, USA. orfeas.liangos@caritaschristi.org
authors: Orfeas
authors: O
authors: Liangos
authors: Alexey
authors: A
authors: Kolyada
authors: Hocine
authors: H
authors: Tighiouart
authors: Mary C
authors: MC
authors: Perianayagam
authors: Ron
authors: R
authors: Wald
authors: Bertrand L
authors: BL
authors: Jaber
mesh_terms: D058186:Acute Kidney Injury / Q000097:blood* / Q000209:etiology; D000368:Aged; D015415:Biomarkers / Q000097:blood; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D015331:Cohort Studies; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D016209:Interleukin-8 / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000097:blood* / Q000209:etiology; D011446:Prospective Studies
chemical_list: D015415:Biomarkers; D016209:Interleukin-8; D003404:Creatinine